Growth Metrics

Gilead Sciences (GILD) Total Debt (2016 - 2025)

Historic Total Debt for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $24.9 billion.

  • Gilead Sciences' Total Debt rose 727.77% to $24.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 billion, marking a year-over-year increase of 727.77%. This contributed to the annual value of $26.7 billion for FY2024, which is 689.96% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Total Debt is $24.9 billion, which was up 727.77% from $24.9 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Total Debt peaked at $30.2 billion during Q2 2021, and registered a low of $23.2 billion during Q3 2024.
  • Over the past 5 years, Gilead Sciences' median Total Debt value was $25.2 billion (recorded in 2022), while the average stood at $25.9 billion.
  • Within the past 5 years, the most significant YoY rise in Gilead Sciences' Total Debt was 2519.71% (2021), while the steepest drop was 1498.95% (2021).
  • Quarter analysis of 5 years shows Gilead Sciences' Total Debt stood at $26.7 billion in 2021, then decreased by 5.49% to $25.2 billion in 2022, then dropped by 0.96% to $25.0 billion in 2023, then grew by 6.9% to $26.7 billion in 2024, then dropped by 6.63% to $24.9 billion in 2025.
  • Its Total Debt stands at $24.9 billion for Q3 2025, versus $24.9 billion for Q2 2025 and $25.0 billion for Q1 2025.